Claire Fieschi
Overview
Explore the profile of Claire Fieschi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
5411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ottavy G, Camous L, Fieschi C, Torre L, Pommier J
J Cardiothorac Surg
. 2025 Jan;
20(1):17.
PMID: 39755690
Background: The medico-surgical management of cardiac tumors when there is a suspicion of malignancy is complex. Moreover, in a critically ill setting, the choice of diagnostic tools seems crucial. Case...
2.
Soulard M, Galicier L, Mahlaoui N, Fieschi C, Deshayes S, Gobert D, et al.
Blood Adv
. 2024 Sep;
8(24):6171-6182.
PMID: 39348667
Predominantly antibody deficiencies have an estimated prevalence of >1 in 25 000. Their classical phenotype entails the association of autoimmune manifestations with increased susceptibility to infections. Up to 8% of...
3.
Guillemin C, Bellon N, Jachiet M, Barbarot S, Bourrat E, Chiaverini C, et al.
J Am Acad Dermatol
. 2024 Sep;
92(1):165-168.
PMID: 39343308
No abstract available.
4.
Viallard J, Parrens M, Blanco P, Moreau J, Oksenhendler E, Fieschi C
J Clin Immunol
. 2024 Jan;
44(2):46.
PMID: 38231432
Purpose: About 25% of patients with common variable immunodeficiency disease (CVID) have splenomegaly, necessitating sometimes splenectomy whom consequences on the immunological profile of CVID patients have never been studied. We...
5.
Le Voyer T, Parent A, Liu X, Cederholm A, Gervais A, Rosain J, et al.
Nature
. 2023 Nov;
623(7988):803-813.
PMID: 37938781
Patients with autoimmune polyendocrinopathy syndrome type 1 (APS-1) caused by autosomal recessive AIRE deficiency produce autoantibodies that neutralize type I interferons (IFNs), conferring a predisposition to life-threatening COVID-19 pneumonia. Here...
6.
Collet A, Attias P, Lacou M, Fieschi C, Moktefi A, Sannier A, et al.
Leuk Lymphoma
. 2023 Jul;
64(11):1857-1863.
PMID: 37493601
No abstract available.
7.
Coustal C, Goulabchand R, Labauge P, Guilpain P, Carra-Dalliere C, Januel E, et al.
Neurology
. 2023 Jul;
101(15):e1560-e1566.
PMID: 37487754
Objectives: CTLA4 deficiency (CTLA4d) is a disease with multisystem autoimmune features, including neurologic manifestations. We aimed to describe neurologic involvement in these patients. Methods: We performed a cross-sectional observational study...
8.
Sorin B, Fadlallah J, Garzaro M, Vigneron J, Bertinchamp R, Boutboul D, et al.
Ann Hematol
. 2023 Jun;
102(8):2059-2068.
PMID: 37386347
Data on mTOR inhibitors (mTORi) in autoimmune cytopenia (AIC), in adults are scarce. We retrospectively analysed 30 cases of refractory or relapsing AIC treated with an mTORi-based therapy. Eleven warm...
9.
Arlabosse T, Materna M, Riccio O, Schnider C, Angelini F, Perreau M, et al.
J Clin Immunol
. 2023 Jun;
43(7):1674.
PMID: 37341861
No abstract available.
10.
Arlabosse T, Materna M, Riccio O, Schnider C, Angelini F, Perreau M, et al.
J Clin Immunol
. 2023 Jun;
43(7):1566-1580.
PMID: 37273120
Patients with autosomal dominant (AD) hyper-IgE syndrome (HIES) suffer from a constellation of manifestations including recurrent bacterial and fungal infections, severe atopy, and skeletal abnormalities. This condition is typically caused...